Get started
Work

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen

Year: 2019
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2019-123126
Authors: Katerina Pavenski, Paul Knoebl, Marie Scully, Johanna A. Kremer Hovinga, Paul Coppo, Flora Peyvandi, Spero Cataland, Ara Metjian, Javier De La Rubia, Hilde De Winter, Rui de Passos Sousa, Filip Callewaert
Institutions: St. Michael's Hospital, University of Toronto, Medical University of Vienna, University College London Hospitals NHS Foundation Trust, National Institute for Health and Care Research, UCL Biomedical Research Centre, University College London, University of Bern, University Hospital of Bern, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, The Ohio State University, Duke University, Duke Medical Center, Hospital Universitario Doctor Peset, Ablynx (Belgium), Sanofi (Portugal), Sanofi (Belgium)
Language: English
Subfield: Immunology
Open Access status: closed
OpenAlex ID: W2989409772
Cites:
Cited by: 2
Related to: 10